In Wolff‑Parkinson‑White syndrome, a markedly negative delta wave in the inferior leads (II, III, aVF) most likely indicates an accessory pathway located where?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 16, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

WPW Syndrome: Pathway Localization Based on Inferior Lead Delta Wave Polarity

A markedly negative delta wave in the inferior leads (II, III, aVF) in Wolff-Parkinson-White syndrome most reliably indicates a posteroseptal (inferoseptal) accessory pathway location.

Electrocardiographic Localization Principles

The delta wave polarity reflects the initial site of ventricular pre-excitation, with negative deflections in specific leads indicating activation away from those recording electrodes 1, 2.

Posteroseptal Pathway Characteristics

When delta waves are negative in leads II, III, and aVF, the accessory pathway is located in the posteroseptal region 1, 2:

  • All 16 patients with posteroseptal pathways in a validated mapping study demonstrated negative delta waves in the inferior leads (II, III, aVF) 1
  • These pathways additionally show a superior QRS axis and an R wave less than S wave in lead V1 1
  • The ACC/AHA/ESC guidelines specifically note that posteroseptal (inferoseptal) accessory pathways are associated with negative P waves in leads II, III, and aVF during tachycardia, reflecting the anatomic relationship 3

Distinguishing Right vs. Left Posteroseptal Location

Once a posteroseptal location is identified by negative inferior lead delta waves, further refinement is possible 4, 5:

  • Right posteroseptal pathways show negative QRS polarity in lead V1 (100% sensitivity) and positive polarity in lead V2 (90% sensitivity) 4
  • Left posteroseptal pathways never show negative QRS polarity in lead V1; instead, V1 and V2 are either biphasic or positive 4
  • The R/S ratio in V1 can distinguish right from left sided pathways with 100% accuracy in pediatric algorithms 5

Alternative Pathway Locations (For Comparison)

To ensure accurate interpretation, recognize that other pathway locations produce distinctly different patterns 1, 2:

  • Left lateral pathways: Negative delta waves in leads I or aVL, normal QRS axis, early precordial R-wave transition (sensitivity 83%) 1
  • Left posterior pathways: Negative delta waves in II, III, aVF with a prominent R wave in V1 (sensitivity 88%) 1
  • Right free wall pathways: Negative delta waves in aVR, normal QRS axis, R-wave transition in V3-V5 (sensitivity 100%) 1
  • Anteroseptal pathways: Negative delta waves in V1 and V2, normal QRS axis (sensitivity 100%) 1

Clinical Validation and Accuracy

The electrocardiographic criteria for posteroseptal pathways have been rigorously validated 1, 2:

  • Overall accuracy of ECG localization algorithms reaches 90-92% when correlated with successful ablation sites 1, 5
  • Posteroseptal pathway identification has 100% sensitivity when negative delta waves are present in all three inferior leads 1
  • Mid-septal accessory pathways show 100% sensitivity and 98% specificity for ECG localization 2

Important Clinical Caveat

A truly negative delta wave in lead II (not just III and aVF) predicts ablation within the coronary venous system with 100% sensitivity and specificity, indicating a subepicardial location requiring specialized ablation techniques 2. This distinction is critical for procedural planning, as standard endocardial ablation may fail in these cases 2.

Diagnostic Pitfall

Negative delta waves in inferior leads can mimic pathological Q waves of old inferior myocardial infarction 6. When Q waves appear in inferior leads in younger patients or those without typical coronary risk factors, consider WPW syndrome in the differential diagnosis and look for the characteristic slurred upstroke and short PR interval 6.

References

3
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

A patient previously treated with methimazole for hyperthyroidism, now off all thyroid medication, has normal free T3 and free T4, mildly suppressed thyroid‑stimulating hormone, and is completely asymptomatic—does he/she require any further thyroid treatment?
In adult ICU patients with hypotension or shock, which vasopressor(s) should be selected for septic/vasodilatory shock, cardiogenic shock, anaphylactic shock, and refractory shock, taking into account heart rate, cardiac output, and arrhythmia profile?
What are the management options for a patient with high‑risk non‑muscle‑invasive bladder cancer according to the EAU guidelines?
What is the mortality rate for adult patients who develop delirium tremens from chronic alcohol use?
In a pregnant woman of advanced maternal age, nulliparous, with a first-degree relative with preeclampsia, who conceived via oocyte donation, has endometriosis, two prior spontaneous abortions (one after curettage), and isolated ANA positivity, do these additional factors increase her risk of preeclampsia and necessitate intensified surveillance, or are they primarily risk factors for other obstetric complications?
When should fresh‑frozen plasma be transfused in a chronic liver disease patient with portal hypertension who has achieved hemostasis after endoscopic variceal ligation?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question